Semaglutide has been approved by the FDA for use as a weight loss medication in addition to its use for managing blood sugar levels in people with type 2 diabetes
(I have since canceled that credit card, as a precaution.) It is perhaps revealing, though, that when I contacted the company not in my capacity as another disgruntled customer but as a reporter writing an article about its business practices, Zealthy wasby some miracle, or workaround in their otherwise ironclad terms of serviceable to reverse its policy and refund my $866
The standard melanotan-1 dosage protocol for research use involves subcutaneous injection of 0.251.0mg daily, administered 3060 minutes before controlled UV exposure, with reconstituted peptide stored at 28C and used within 28 days
Common early side effects include nausea, vomiting, diarrhoea, and reduced appetite, consistent with the GLP-1 receptor agonist class